nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—psoriatic arthritis	0.761	1	CbGaD
Cilazapril—ABCB1—Methylprednisolone—psoriatic arthritis	0.0409	0.279	CbGbCtD
Cilazapril—ABCB1—Betamethasone—psoriatic arthritis	0.0266	0.182	CbGbCtD
Cilazapril—ABCB1—Prednisolone—psoriatic arthritis	0.0262	0.179	CbGbCtD
Cilazapril—ABCB1—Prednisone—psoriatic arthritis	0.0248	0.169	CbGbCtD
Cilazapril—ABCB1—Dexamethasone—psoriatic arthritis	0.0155	0.106	CbGbCtD
Cilazapril—ABCB1—Methotrexate—psoriatic arthritis	0.0124	0.0849	CbGbCtD
Cilazapril—Fosinopril—ACE—psoriatic arthritis	0.00107	0.136	CrCbGaD
Cilazapril—Perindopril—ACE—psoriatic arthritis	0.000875	0.111	CrCbGaD
Cilazapril—Spirapril—ACE—psoriatic arthritis	0.000866	0.109	CrCbGaD
Cilazapril—Moexipril—ACE—psoriatic arthritis	0.00083	0.105	CrCbGaD
Cilazapril—Quinapril—ACE—psoriatic arthritis	0.000771	0.0974	CrCbGaD
Cilazapril—Lisinopril—ACE—psoriatic arthritis	0.000771	0.0974	CrCbGaD
Cilazapril—Ramipril—ACE—psoriatic arthritis	0.000747	0.0944	CrCbGaD
Cilazapril—Trandolapril—ACE—psoriatic arthritis	0.000747	0.0944	CrCbGaD
Cilazapril—Benazepril—ACE—psoriatic arthritis	0.000671	0.0848	CrCbGaD
Cilazapril—Enalapril—ACE—psoriatic arthritis	0.000566	0.0715	CrCbGaD
Cilazapril—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000172	0.00203	CcSEcCtD
Cilazapril—Hypertension—Triamcinolone—psoriatic arthritis	0.000172	0.00203	CcSEcCtD
Cilazapril—Hypertension—Methylprednisolone—psoriatic arthritis	0.000171	0.00203	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000171	0.00202	CcSEcCtD
Cilazapril—Myalgia—Triamcinolone—psoriatic arthritis	0.000169	0.002	CcSEcCtD
Cilazapril—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000169	0.002	CcSEcCtD
Cilazapril—Myalgia—Methylprednisolone—psoriatic arthritis	0.000169	0.002	CcSEcCtD
Cilazapril—Anxiety—Methylprednisolone—psoriatic arthritis	0.000168	0.00199	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000168	0.00198	CcSEcCtD
Cilazapril—Flushing—Prednisone—psoriatic arthritis	0.000168	0.00198	CcSEcCtD
Cilazapril—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000167	0.00198	CcSEcCtD
Cilazapril—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000167	0.00198	CcSEcCtD
Cilazapril—Discomfort—Triamcinolone—psoriatic arthritis	0.000167	0.00198	CcSEcCtD
Cilazapril—Discomfort—Methylprednisolone—psoriatic arthritis	0.000167	0.00197	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000167	0.00197	CcSEcCtD
Cilazapril—Dry mouth—Triamcinolone—psoriatic arthritis	0.000166	0.00196	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—psoriatic arthritis	0.000165	0.00195	CcSEcCtD
Cilazapril—Angioedema—Dexamethasone—psoriatic arthritis	0.000165	0.00195	CcSEcCtD
Cilazapril—Angioedema—Betamethasone—psoriatic arthritis	0.000165	0.00195	CcSEcCtD
Cilazapril—Angiopathy—Prednisone—psoriatic arthritis	0.000164	0.00194	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000163	0.00193	CcSEcCtD
Cilazapril—Confusional state—Methylprednisolone—psoriatic arthritis	0.000163	0.00193	CcSEcCtD
Cilazapril—Immune system disorder—Prednisone—psoriatic arthritis	0.000163	0.00193	CcSEcCtD
Cilazapril—Malaise—Betamethasone—psoriatic arthritis	0.000163	0.00192	CcSEcCtD
Cilazapril—Malaise—Dexamethasone—psoriatic arthritis	0.000163	0.00192	CcSEcCtD
Cilazapril—Oedema—Triamcinolone—psoriatic arthritis	0.000162	0.00192	CcSEcCtD
Cilazapril—Vertigo—Betamethasone—psoriatic arthritis	0.000162	0.00192	CcSEcCtD
Cilazapril—Vertigo—Dexamethasone—psoriatic arthritis	0.000162	0.00192	CcSEcCtD
Cilazapril—Syncope—Betamethasone—psoriatic arthritis	0.000162	0.00191	CcSEcCtD
Cilazapril—Syncope—Dexamethasone—psoriatic arthritis	0.000162	0.00191	CcSEcCtD
Cilazapril—Arrhythmia—Prednisone—psoriatic arthritis	0.000161	0.00191	CcSEcCtD
Cilazapril—Shock—Triamcinolone—psoriatic arthritis	0.00016	0.00189	CcSEcCtD
Cilazapril—Insomnia—Prednisolone—psoriatic arthritis	0.00016	0.00189	CcSEcCtD
Cilazapril—Alopecia—Prednisone—psoriatic arthritis	0.00016	0.00189	CcSEcCtD
Cilazapril—Shock—Methylprednisolone—psoriatic arthritis	0.000159	0.00188	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000159	0.00188	CcSEcCtD
Cilazapril—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000159	0.00188	CcSEcCtD
Cilazapril—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000159	0.00188	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—psoriatic arthritis	0.000158	0.00187	CcSEcCtD
Cilazapril—Paraesthesia—Prednisolone—psoriatic arthritis	0.000158	0.00187	CcSEcCtD
Cilazapril—Tachycardia—Triamcinolone—psoriatic arthritis	0.000158	0.00187	CcSEcCtD
Cilazapril—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000158	0.00187	CcSEcCtD
Cilazapril—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000157	0.00186	CcSEcCtD
Cilazapril—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000157	0.00186	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000157	0.00185	CcSEcCtD
Cilazapril—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000157	0.00185	CcSEcCtD
Cilazapril—Hypertension—Betamethasone—psoriatic arthritis	0.000156	0.00184	CcSEcCtD
Cilazapril—Hypertension—Dexamethasone—psoriatic arthritis	0.000156	0.00184	CcSEcCtD
Cilazapril—Myalgia—Dexamethasone—psoriatic arthritis	0.000154	0.00182	CcSEcCtD
Cilazapril—Myalgia—Betamethasone—psoriatic arthritis	0.000154	0.00182	CcSEcCtD
Cilazapril—Anxiety—Dexamethasone—psoriatic arthritis	0.000153	0.00181	CcSEcCtD
Cilazapril—Anxiety—Betamethasone—psoriatic arthritis	0.000153	0.00181	CcSEcCtD
Cilazapril—Discomfort—Dexamethasone—psoriatic arthritis	0.000152	0.0018	CcSEcCtD
Cilazapril—Discomfort—Betamethasone—psoriatic arthritis	0.000152	0.0018	CcSEcCtD
Cilazapril—Hypotension—Methylprednisolone—psoriatic arthritis	0.000151	0.00179	CcSEcCtD
Cilazapril—Pain—Prednisolone—psoriatic arthritis	0.000151	0.00179	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—psoriatic arthritis	0.00015	0.00177	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000149	0.00176	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—psoriatic arthritis	0.000148	0.00175	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000148	0.00175	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000148	0.00175	CcSEcCtD
Cilazapril—Oedema—Dexamethasone—psoriatic arthritis	0.000147	0.00174	CcSEcCtD
Cilazapril—Oedema—Betamethasone—psoriatic arthritis	0.000147	0.00174	CcSEcCtD
Cilazapril—Insomnia—Triamcinolone—psoriatic arthritis	0.000147	0.00174	CcSEcCtD
Cilazapril—Insomnia—Methylprednisolone—psoriatic arthritis	0.000146	0.00173	CcSEcCtD
Cilazapril—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000146	0.00172	CcSEcCtD
Cilazapril—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000146	0.00172	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000145	0.00172	CcSEcCtD
Cilazapril—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000145	0.00172	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—psoriatic arthritis	0.000145	0.00172	CcSEcCtD
Cilazapril—Anaemia—Prednisone—psoriatic arthritis	0.000145	0.00172	CcSEcCtD
Cilazapril—Shock—Betamethasone—psoriatic arthritis	0.000145	0.00171	CcSEcCtD
Cilazapril—Shock—Dexamethasone—psoriatic arthritis	0.000145	0.00171	CcSEcCtD
Cilazapril—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000145	0.00171	CcSEcCtD
Cilazapril—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000144	0.00171	CcSEcCtD
Cilazapril—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000144	0.00171	CcSEcCtD
Cilazapril—Tachycardia—Dexamethasone—psoriatic arthritis	0.000144	0.0017	CcSEcCtD
Cilazapril—Tachycardia—Betamethasone—psoriatic arthritis	0.000144	0.0017	CcSEcCtD
Cilazapril—Angioedema—Prednisone—psoriatic arthritis	0.000144	0.0017	CcSEcCtD
Cilazapril—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000143	0.00169	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000143	0.00169	CcSEcCtD
Cilazapril—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000143	0.00169	CcSEcCtD
Cilazapril—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000142	0.00168	CcSEcCtD
Cilazapril—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000142	0.00168	CcSEcCtD
Cilazapril—Malaise—Prednisone—psoriatic arthritis	0.000142	0.00168	CcSEcCtD
Cilazapril—Vertigo—Prednisone—psoriatic arthritis	0.000141	0.00167	CcSEcCtD
Cilazapril—Syncope—Prednisone—psoriatic arthritis	0.000141	0.00167	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—psoriatic arthritis	0.000141	0.00166	CcSEcCtD
Cilazapril—Anorexia—Dexamethasone—psoriatic arthritis	0.00014	0.00166	CcSEcCtD
Cilazapril—Anorexia—Betamethasone—psoriatic arthritis	0.00014	0.00166	CcSEcCtD
Cilazapril—Urticaria—Prednisolone—psoriatic arthritis	0.00014	0.00166	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00014	0.00166	CcSEcCtD
Cilazapril—Fatigue—Triamcinolone—psoriatic arthritis	0.00014	0.00166	CcSEcCtD
Cilazapril—Fatigue—Methylprednisolone—psoriatic arthritis	0.00014	0.00165	CcSEcCtD
Cilazapril—Pain—Triamcinolone—psoriatic arthritis	0.000139	0.00164	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisone—psoriatic arthritis	0.000138	0.00163	CcSEcCtD
Cilazapril—Hypotension—Dexamethasone—psoriatic arthritis	0.000138	0.00163	CcSEcCtD
Cilazapril—Hypotension—Betamethasone—psoriatic arthritis	0.000138	0.00163	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—psoriatic arthritis	0.000137	0.00162	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—psoriatic arthritis	0.000136	0.00161	CcSEcCtD
Cilazapril—Hypertension—Prednisone—psoriatic arthritis	0.000136	0.0016	CcSEcCtD
Cilazapril—Chills—Methotrexate—psoriatic arthritis	0.000135	0.0016	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000134	0.00159	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000134	0.00159	CcSEcCtD
Cilazapril—Arthralgia—Prednisone—psoriatic arthritis	0.000134	0.00158	CcSEcCtD
Cilazapril—Myalgia—Prednisone—psoriatic arthritis	0.000134	0.00158	CcSEcCtD
Cilazapril—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000134	0.00158	CcSEcCtD
Cilazapril—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000133	0.00158	CcSEcCtD
Cilazapril—Anxiety—Prednisone—psoriatic arthritis	0.000133	0.00158	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—psoriatic arthritis	0.000133	0.00158	CcSEcCtD
Cilazapril—Insomnia—Dexamethasone—psoriatic arthritis	0.000133	0.00158	CcSEcCtD
Cilazapril—Insomnia—Betamethasone—psoriatic arthritis	0.000133	0.00158	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000133	0.00157	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000132	0.00157	CcSEcCtD
Cilazapril—Paraesthesia—Betamethasone—psoriatic arthritis	0.000132	0.00156	CcSEcCtD
Cilazapril—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000132	0.00156	CcSEcCtD
Cilazapril—Discomfort—Prednisone—psoriatic arthritis	0.000132	0.00156	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00013	0.00154	CcSEcCtD
Cilazapril—Dyspepsia—Betamethasone—psoriatic arthritis	0.00013	0.00153	CcSEcCtD
Cilazapril—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00013	0.00153	CcSEcCtD
Cilazapril—Urticaria—Triamcinolone—psoriatic arthritis	0.000129	0.00153	CcSEcCtD
Cilazapril—Urticaria—Methylprednisolone—psoriatic arthritis	0.000129	0.00152	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—psoriatic arthritis	0.000129	0.00152	CcSEcCtD
Cilazapril—Oedema—Prednisone—psoriatic arthritis	0.000128	0.00152	CcSEcCtD
Cilazapril—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000128	0.00151	CcSEcCtD
Cilazapril—Decreased appetite—Betamethasone—psoriatic arthritis	0.000128	0.00151	CcSEcCtD
Cilazapril—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000128	0.00151	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000127	0.0015	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000127	0.0015	CcSEcCtD
Cilazapril—Fatigue—Betamethasone—psoriatic arthritis	0.000127	0.0015	CcSEcCtD
Cilazapril—Fatigue—Dexamethasone—psoriatic arthritis	0.000127	0.0015	CcSEcCtD
Cilazapril—Shock—Prednisone—psoriatic arthritis	0.000126	0.00149	CcSEcCtD
Cilazapril—Pain—Dexamethasone—psoriatic arthritis	0.000126	0.00149	CcSEcCtD
Cilazapril—Pain—Betamethasone—psoriatic arthritis	0.000126	0.00149	CcSEcCtD
Cilazapril—Tachycardia—Prednisone—psoriatic arthritis	0.000125	0.00148	CcSEcCtD
Cilazapril—Skin disorder—Prednisone—psoriatic arthritis	0.000125	0.00147	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000124	0.00147	CcSEcCtD
Cilazapril—Anorexia—Prednisone—psoriatic arthritis	0.000122	0.00145	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000122	0.00144	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—psoriatic arthritis	0.000121	0.00144	CcSEcCtD
Cilazapril—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000121	0.00144	CcSEcCtD
Cilazapril—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000121	0.00144	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00012	0.00142	CcSEcCtD
Cilazapril—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00012	0.00142	CcSEcCtD
Cilazapril—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00012	0.00141	CcSEcCtD
Cilazapril—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000119	0.00141	CcSEcCtD
Cilazapril—Malaise—Methotrexate—psoriatic arthritis	0.000118	0.0014	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—psoriatic arthritis	0.000118	0.0014	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—psoriatic arthritis	0.000118	0.00139	CcSEcCtD
Cilazapril—Urticaria—Dexamethasone—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Cilazapril—Urticaria—Betamethasone—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Cilazapril—Dizziness—Prednisolone—psoriatic arthritis	0.000117	0.00138	CcSEcCtD
Cilazapril—Asthenia—Triamcinolone—psoriatic arthritis	0.000116	0.00138	CcSEcCtD
Cilazapril—Abdominal pain—Betamethasone—psoriatic arthritis	0.000116	0.00138	CcSEcCtD
Cilazapril—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000116	0.00138	CcSEcCtD
Cilazapril—Asthenia—Methylprednisolone—psoriatic arthritis	0.000116	0.00137	CcSEcCtD
Cilazapril—Insomnia—Prednisone—psoriatic arthritis	0.000116	0.00137	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—psoriatic arthritis	0.000115	0.00136	CcSEcCtD
Cilazapril—Pruritus—Triamcinolone—psoriatic arthritis	0.000115	0.00136	CcSEcCtD
Cilazapril—Cough—Methotrexate—psoriatic arthritis	0.000115	0.00136	CcSEcCtD
Cilazapril—Pruritus—Methylprednisolone—psoriatic arthritis	0.000115	0.00136	CcSEcCtD
Cilazapril—Dyspepsia—Prednisone—psoriatic arthritis	0.000113	0.00134	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—psoriatic arthritis	0.000112	0.00132	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—psoriatic arthritis	0.000111	0.00132	CcSEcCtD
Cilazapril—Rash—Prednisolone—psoriatic arthritis	0.000111	0.00132	CcSEcCtD
Cilazapril—Dermatitis—Prednisolone—psoriatic arthritis	0.000111	0.00131	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000111	0.00131	CcSEcCtD
Cilazapril—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000111	0.00131	CcSEcCtD
Cilazapril—Fatigue—Prednisone—psoriatic arthritis	0.000111	0.00131	CcSEcCtD
Cilazapril—Headache—Prednisolone—psoriatic arthritis	0.000111	0.00131	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—psoriatic arthritis	0.00011	0.00131	CcSEcCtD
Cilazapril—Constipation—Prednisone—psoriatic arthritis	0.00011	0.0013	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—psoriatic arthritis	0.000108	0.00128	CcSEcCtD
Cilazapril—Dizziness—Triamcinolone—psoriatic arthritis	0.000107	0.00127	CcSEcCtD
Cilazapril—Dizziness—Methylprednisolone—psoriatic arthritis	0.000107	0.00127	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—psoriatic arthritis	0.000106	0.00125	CcSEcCtD
Cilazapril—Asthenia—Dexamethasone—psoriatic arthritis	0.000106	0.00125	CcSEcCtD
Cilazapril—Asthenia—Betamethasone—psoriatic arthritis	0.000106	0.00125	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Cilazapril—Nausea—Prednisolone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Cilazapril—Pruritus—Dexamethasone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Cilazapril—Pruritus—Betamethasone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Cilazapril—Vomiting—Triamcinolone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Cilazapril—Vomiting—Methylprednisolone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Cilazapril—Rash—Triamcinolone—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Dermatitis—Triamcinolone—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Rash—Methylprednisolone—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Urticaria—Prednisone—psoriatic arthritis	0.000102	0.00121	CcSEcCtD
Cilazapril—Headache—Triamcinolone—psoriatic arthritis	0.000102	0.0012	CcSEcCtD
Cilazapril—Headache—Methylprednisolone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Cilazapril—Abdominal pain—Prednisone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Cilazapril—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000101	0.00119	CcSEcCtD
Cilazapril—Diarrhoea—Betamethasone—psoriatic arthritis	0.000101	0.00119	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—psoriatic arthritis	0.0001	0.00118	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	9.76e-05	0.00115	CcSEcCtD
Cilazapril—Dizziness—Dexamethasone—psoriatic arthritis	9.74e-05	0.00115	CcSEcCtD
Cilazapril—Dizziness—Betamethasone—psoriatic arthritis	9.74e-05	0.00115	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—psoriatic arthritis	9.69e-05	0.00115	CcSEcCtD
Cilazapril—Nausea—Triamcinolone—psoriatic arthritis	9.64e-05	0.00114	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—psoriatic arthritis	9.62e-05	0.00114	CcSEcCtD
Cilazapril—Nausea—Methylprednisolone—psoriatic arthritis	9.62e-05	0.00114	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—psoriatic arthritis	9.55e-05	0.00113	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—psoriatic arthritis	9.53e-05	0.00113	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—psoriatic arthritis	9.45e-05	0.00112	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—psoriatic arthritis	9.43e-05	0.00112	CcSEcCtD
Cilazapril—Vomiting—Betamethasone—psoriatic arthritis	9.36e-05	0.00111	CcSEcCtD
Cilazapril—Vomiting—Dexamethasone—psoriatic arthritis	9.36e-05	0.00111	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—psoriatic arthritis	9.32e-05	0.0011	CcSEcCtD
Cilazapril—Rash—Dexamethasone—psoriatic arthritis	9.28e-05	0.0011	CcSEcCtD
Cilazapril—Rash—Betamethasone—psoriatic arthritis	9.28e-05	0.0011	CcSEcCtD
Cilazapril—Dermatitis—Dexamethasone—psoriatic arthritis	9.28e-05	0.0011	CcSEcCtD
Cilazapril—Dermatitis—Betamethasone—psoriatic arthritis	9.28e-05	0.0011	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	9.25e-05	0.00109	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—psoriatic arthritis	9.24e-05	0.00109	CcSEcCtD
Cilazapril—Headache—Dexamethasone—psoriatic arthritis	9.22e-05	0.00109	CcSEcCtD
Cilazapril—Headache—Betamethasone—psoriatic arthritis	9.22e-05	0.00109	CcSEcCtD
Cilazapril—Asthenia—Prednisone—psoriatic arthritis	9.2e-05	0.00109	CcSEcCtD
Cilazapril—Pain—Methotrexate—psoriatic arthritis	9.16e-05	0.00108	CcSEcCtD
Cilazapril—Pruritus—Prednisone—psoriatic arthritis	9.07e-05	0.00107	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—psoriatic arthritis	8.83e-05	0.00104	CcSEcCtD
Cilazapril—Diarrhoea—Prednisone—psoriatic arthritis	8.77e-05	0.00104	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—psoriatic arthritis	8.76e-05	0.00104	CcSEcCtD
Cilazapril—Nausea—Dexamethasone—psoriatic arthritis	8.75e-05	0.00103	CcSEcCtD
Cilazapril—Nausea—Betamethasone—psoriatic arthritis	8.75e-05	0.00103	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—psoriatic arthritis	8.51e-05	0.00101	CcSEcCtD
Cilazapril—Dizziness—Prednisone—psoriatic arthritis	8.48e-05	0.001	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—psoriatic arthritis	8.47e-05	0.001	CcSEcCtD
Cilazapril—Vomiting—Prednisone—psoriatic arthritis	8.15e-05	0.000964	CcSEcCtD
Cilazapril—Rash—Prednisone—psoriatic arthritis	8.09e-05	0.000956	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—psoriatic arthritis	8.08e-05	0.000956	CcSEcCtD
Cilazapril—Headache—Prednisone—psoriatic arthritis	8.03e-05	0.00095	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—psoriatic arthritis	7.9e-05	0.000934	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—psoriatic arthritis	7.69e-05	0.00091	CcSEcCtD
Cilazapril—Nausea—Prednisone—psoriatic arthritis	7.62e-05	0.000901	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—psoriatic arthritis	7.58e-05	0.000897	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—psoriatic arthritis	7.33e-05	0.000867	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—psoriatic arthritis	7.09e-05	0.000838	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—psoriatic arthritis	6.81e-05	0.000806	CcSEcCtD
Cilazapril—Rash—Methotrexate—psoriatic arthritis	6.76e-05	0.000799	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—psoriatic arthritis	6.75e-05	0.000799	CcSEcCtD
Cilazapril—Headache—Methotrexate—psoriatic arthritis	6.71e-05	0.000794	CcSEcCtD
Cilazapril—Nausea—Methotrexate—psoriatic arthritis	6.37e-05	0.000753	CcSEcCtD
